BEAM-301

N/A

Report date: 2025/07/28 17:40:12

Base Information

Drug NameBEAM-301
Drug Alias NameBEAM301
ClassificationCell and gene therapy > Gene therapy > LNPCell and gene therapy > Gene therapy > Gene editing > Base editing
Mechanisms of ActionGene transferenceGlucose-6-phosphatase inhibitors
TargetsGlucose-6-phosphatase
Therapy Area/IndicationsGlycogen Storage Disease Type I
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBeam Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBeam Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGlycogen Storage Disease Type I
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A